Arkolith/Insider Trading/OKUR/Form 4

Saccomano Nicholas A

President and CEO, DirectorOnKure Therapeutics, Inc. (OKUR) · full profile →Form 4 · filed Dec 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$258
Net Open-Market Flow
-$258
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2025Sell(S)87$2.97$2587K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001609284-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML